CytoMed Therapeutics (GDTC) Earnings Date & Reports

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

GDTC is expected to report earnings to fall 66.67% to -3 cents per share on May 28

CytoMed Therapeutics GDTC Stock Earnings Reports

Q1'25

Est.

$-0.04

Q4'24

Missed

by $0.08

Q3'24

Est.

$-0.04

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.04

The last earnings report on May 05 showed earnings per share of -11 cents, missing the estimate of -3 cents. With 8.01K shares outstanding, the current market capitalization sits at 23.31M.

View a ticker or compare two or three

Compare

GDTC